Guselkumab
Guselkumab is a human monoclonal antibody directed against interleukin 23 (IL23). Guselkumab is being used in the treatment of plaque psoriasis.What can Sanquin do for you?
- Measure drug levels of free drug in the serum using an validated ELISA.
- Measure the immunogenicity of guselkumab.
- Provide assay reagents or co-develop novel testing strategies.
- Folllowing ISO, FDA/EMA, RUO guidelines.
Enquire about our drug level and ADA assays by emailing us at [email protected].